Statement from Novogen Limited
October 30 2006 - 9:06AM
PR Newswire (US)
STAMFORD, Conn., and SYDNEY, Australia, Oct. 30
/PRNewswire-FirstCall/ -- Novogen Limited (NASDAQ:NVGN)(ASX:NRT)
advises the market that Dr. Graham Kelly, has now ceased his
operational and executive functions with the Company and will
continue to provide ongoing scientific services to the Novogen
Group on a consultancy basis. DATASOURCE: Novogen Limited CONTACT:
Christopher Naughton, Managing Director of Novogen Limited, +61
(02) 9878 0088; or David Sheon, +1-202-518-6321, for Novogen
Limited Web site: http://www.novogen.com/
Copyright
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Jul 2023 to Jul 2024